Parasympathetic Dominant Autonomic Dysfunction in Charcot-Marie-Tooth Disease Type 2J with the <i>MPZ</i> Thr124Met Mutation

Internal Medicine - Tập 54 Số 15 - Trang 1919-1922 - 2015
Naoki Tokuda1, Yu‐ichi Noto1, Fukiko Kitani‐Morii1, Ai Hamano1, Takashi Kasai1, Kiyoto Shiga2, Ikuko Mizuta1, Fumitoshi Niwa3, Masanori Nakagawa3, Toshiki Mizuno1
1Department of Neurology, Kyoto Prefectural University of Medicine, Graduate School of Medicine, Japan.
2Department of Medical Education and Primary Care, Kyoto Prefectural University of Medicine, Graduate School of Medicine, Japan
3North Medical Center, Kyoto Prefectural University of Medicine, Graduate School of Medicine, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

1. Marrosu MG, Vaccaugiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurol 50: 1397-1401, 1998.

2. Mastaglia FL, Nowak KJ, Stell R, et al. Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy. J Neurol Neurosurg Psychiatry 67: 174-179, 1999.

3. Shy ME, Jáni A, Krajewski K, et al. Phenotypic clustering in MPZ mutations. Brain 127: 371-384, 2004.

4. De Jonghe P, Timmerman V, Ceuterick C, et al. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain 122: 281-290, 1999.

5. Chapon F, Latour P, Diraison P, Schaeffer S, Vandenberghe A. Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene. J Neurol Neurosurg Psychiatry 66: 779-782, 1999.

6. Misu K, Yoshihara T, Shikama Y, et al. An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val). J Neurol Neurosurg Psychiatry 69: 806-811, 2000.

7. Züchner S, Vance JM. Molecular genetics of autosomal-dominant axonal Charcot-Marie-Tooth disease. Neuromolecular Med 8: 63-74, 2006.

8. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17: 354-381, 1996.

9. Seeman P, Mazanec R, Huehne K, Suslíková P, Keller O, Rautenstrauss B. Hearing loss as the first feature of late-onset axonal CMT disease due to a novel P0 mutation. Neurology 63: 733-735, 2004.

10. Kabzinska D, Korwin-Piotrowska T, Drechsler H, Drac H, Hausmanowa-Petrusewicz I, Kochanski A. Late-onset Charcot-Marie-Tooth type 2 disease with hearing impairment associated with a novel Pro105Thr mutation in the MPZ gene. Am J Med Genet A 143A: 2196-2199, 2007.

11. Baloh RH, Jen JC, Kim G, Baloh RW. Chronic cough due to Thr124Met mutation in the peripheral myelin protein zero (MPZ gene). Neurology 62: 1905-1906, 2004.

12. Nakamura N, Kawamura N, Tateishi T, Doi H, Ohyagi Y, Kira J. Predominant parasympathetic involvement in a patient with Charcot-Marie-Tooth disease caused by the MPZ Thr124Met mutation. Rinsho Shinkeigaku (Clinical Neurology) 49: 582-585, 2009 (in Japanese, Abstract in English).

13. Berger P, Niemann A, Suter U. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease). Glia 54: 243-257, 2006.

14. Shy ME. Peripheral neuropathies caused by mutation in the myelin protein zero. J Neurol Sci 242: 55-66, 2006.

15. Hanemann CO, Gabreëls-Festen AA, De Jonghe P. Axon damage in CMT due to mutation in myelin protein P0. Neuromuscul Disord 11: 432, 2001.